The study of endocrine tumors by flow and image cytometry

Endocrine Pathology
Ingrid Zbieranowski, David Murray

Abstract

Both DNA flow and image cytometry are methods that can be used for the quantitative determination of cellular DNA content. Objective, quantitative analysis of cellular morphology can also be obtained using image cytometry. Data thus generated have been shown to be of diagnostic and prognostic use in the study of many solid tumors and would be of particular value in the evaluation of endocrine tumors that show a poor correlation between their histology and biological behavior. The main application of these techniques to endocrine tumors has been in the analysis of thyroid nodules, although a limited number of studies of parathyroid, pituitary, adrenal, and pancreatic neuroendocrine tumors and tumors of the dispersed neuroendocrine system have been reported. Review of these studies shows that in the endocrine organs DNA and morphometric measurements have a very limited role in the diagnosis of individual cases, but are important as prognostic variables. The high incidence of abnormal DNA content in histologically benign lesions of the endocrine glands has important biological implications. Further investigation of this phenomenon may help to elucidate the process of endocrine tumorigenesis.

References

Oct 1, 1979·American Journal of Surgery·G L Irvin, C B Bagwell
Jan 1, 1979·Journal of Cancer Research and Clinical Oncology·G L LukácsI Zs-Nagy
Jan 1, 1991·Cytopathology : Official Journal of the British Society for Clinical Cytology·C CohenB P Whitaker
Feb 1, 1991·Journal of Clinical Pathology·C CopeM Friedlander
Jan 25, 1991·Cell·J M Bishop
Apr 1, 1991·American Journal of Clinical Pathology·H F Frierson
Jun 1, 1991·American Journal of Clinical Pathology·A K el-NaggarJ G Batsakis
Mar 1, 1990·American Journal of Clinical Pathology·T W BauerH S Levin
Oct 1, 1990·Journal of Clinical Pathology·F A CareyC C Bird
Nov 1, 1990·American Journal of Clinical Pathology·R H HrubanM R Melamed
Dec 1, 1990·Cancer·F Graeme-CookC Compton
Jun 1, 1990·American Journal of Clinical Pathology·K A AlanenT J Nevalainen
May 15, 1990·Cancer·F A CareyC C Bird
May 1, 1990·World Journal of Surgery·B K ShentonJ R Farndon
Oct 1, 1990·The American Journal of Surgical Pathology·E S CibasL M Weiss
Aug 1, 1986·Cancer·L BondesonO Ljungberg
Jun 15, 1988·Cancer·H KujariE Nordman
Jun 1, 1989·Human Pathology·G AuerO Ahrens
Jan 1, 1989·Virchows Archiv. A, Pathological Anatomy and Histopathology·H JoensuuK A Alanen
Nov 1, 1989·Pathology, Research and Practice·O Ferrer-RocaJ Martin
Nov 1, 1989·Pathology, Research and Practice·P FelmanP A Bryon
Nov 1, 1989·Pathology, Research and Practice·I SassiA Cantaboni
Nov 1, 1989·Pathology, Research and Practice·C GiardinaV Pesce Delfino
Mar 1, 1989·Journal of Clinical Pathology·T P van ThielP D Bezemer

❮ Previous
Next ❯

Citations

Feb 1, 1994·International Journal of Cancer. Journal International Du Cancer·P SoaresM Sobrinho-Simões
Dec 1, 1994·Endocrine Pathology·Angelika KrämerDieter K Lüdecke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.